Equity · Healthcare
RDY
NYSEDr Reddys Laboratories (RDY)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for RDY to draw a line in its place.
- 52-week range
- 11.39 USD – 15.39 USD
- Avg volume
- 274.3K
as of Nov 4, 2026
Which funds hold Dr Reddys Laboratories (RDY)?
9 of the 45 institutional funds we track reported a Dr Reddys Laboratories position for the quarter ended 30 Jun 2026 — a combined 162.5M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Renaissance Technologies | Held (±25%) | 7,347,028 | 106.5M USD | −6.5% |
| Marshall Wace | Held (±25%) | 2,025,356 | 29.3M USD | −24.0% |
| AQR Capital Management | Held (±25%) | 552,705 | 8.0M USD | +24.1% |
| Millennium Management | Added | 468,375 | 6.8M USD | +721.2% |
| Man Group | Added | 371,768 | 5.4M USD | +404.1% |
| Fisher Asset Management | Trimmed | 180,767 | 2.6M USD | −50.4% |
| D. E. Shaw & Co. | Held (±25%) | 126,525 | 1.8M USD | −8.7% |
| Citadel Advisors | Trimmed | 79,172 | 1.1M USD | −82.3% |
| Balyasny Asset Management | New position | 61,707 | 894K USD | |
| Two Sigma Investments | Exited |
Dr Reddys Laboratories (RDY): frequently asked questions
Which funds own Dr Reddys Laboratories?
9 of the 45 funds we track reported a Dr Reddys Laboratories position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Renaissance Technologies, Marshall Wace and AQR Capital Management. See Funds
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGAR13F filings